The Efficacy of Automated Intermittent Boluses for Continuous Femoral Nerve Block: a Prospective, Randomized Comparison to Continuous Infusions
This study has been completed.
Sponsor:
Medical University of South Carolina
Information provided by:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT01226927
First received: October 21, 2010
Last updated: NA
Last verified: October 2010
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The optimal infusion technique (continuous rate vs. intermittent bolus) for peripheral nerve blocks has not been established. To our knowledge, this is the first study to compare the efficacy of an automated intermittent bolus technique to a continuous rate of infusion of local anesthetic in femoral nerve catheters. We hypothesized that the intermittent bolus technique would provide enhanced analgesia compared to a continuous infusion rate as assessed by intravenous patient-controlled analgesia (IV-PCA) hydromorphone consumption and visual analog scale (VAS) pain scores.
| Condition | Intervention |
|---|---|
|
Arthroplasty, Replacement, Knee Nerve Block |
Other: Automated intermittent bolus |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | The Efficacy of Automated Intermittent Boluses for Continuous Femoral Nerve Block: a Prospective, Randomized Comparison to Continuous Infusions |
Resource links provided by NLM:
Further study details as provided by Medical University of South Carolina:
Primary Outcome Measures:
- Intravenous patient-controlled analgesia opioid consumption [ Time Frame: Cumulative IV-PCA use was recorded until femoral nerve catheter removed on postoperative day 2. ] [ Designated as safety issue: No ]
- Visual analog pain scale score [ Time Frame: Preop; Immediately postoperatively in PACU; Postoperative day (POD) 0 at 8pm; POD 1 at 8am, 2pm & 8pm; POD 2 at 8am ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Visual analog scale patient satisfaction scores [ Time Frame: POD 1 at 8am; POD 2 at 8am ] [ Designated as safety issue: No ]
- Incidence of physician administered "rescue" boluses of the femoral nerve catheter [ Designated as safety issue: No ]
- Hospital length of stay [ Designated as safety issue: No ]
| Enrollment: | 45 |
| Study Start Date: | April 2009 |
| Study Completion Date: | April 2010 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Continuous infusion rate
Patients received a continuous infusion of 0.2% ropivacaine at 10.1 mL/hr via their femoral nerve catheter.
|
Other: Automated intermittent bolus
Automated intermittent bolus delivery method of 0.2% ropivacaine at 5 mL every 30 minutes with a basal infusion of 0.1 mL/hr.
|
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) physical status 1 through 3
- elective, primary, unilateral TKA
Exclusion Criteria:
- patient refusal
- pregnancy
- diabetic neuropathy or any other neurologic or neuromuscular disease
- rheumatoid arthritis
- current coagulopathy
- skin infection at needle insertion site for the femoral or sciatic blocks
- significant renal or hepatic impairment
- unsuccessful femoral or sciatic block or femoral catheter placement
- femoral catheter dislodgement after placement
- inability to understand VAS pain scales
- inability to use an IV-PCA pump
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01226927
Locations
| United States, South Carolina | |
| Medical University of South Carolina | |
| Charleston, South Carolina, United States, 29425 | |
Sponsors and Collaborators
Medical University of South Carolina
Investigators
| Principal Investigator: | Larry C. Field, M.D. | Department of Anesthesia and Perioperative Medicine, Medical University of South Carolina |
More Information
Publications:
| Responsible Party: | Larry C. Field, M.D., Department of Anesthesia and Perioperative Medicine, Medical University of South Carolina |
| ClinicalTrials.gov Identifier: | NCT01226927 History of Changes |
| Other Study ID Numbers: | HR 18880 |
| Study First Received: | October 21, 2010 |
| Last Updated: | October 21, 2010 |
| Health Authority: | United States: Institutional Review Board |
ClinicalTrials.gov processed this record on May 16, 2013